vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and DIODES INC (DIOD). Click either name above to swap in a different company.
DIODES INC is the larger business by last-quarter revenue ($391.6M vs $196.0M, roughly 2.0× Axsome Therapeutics, Inc.). DIODES INC runs the higher net margin — 2.6% vs -14.6%, a 17.2% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 15.4%). DIODES INC produced more free cash flow last quarter ($12.4M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 13.9%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Diodes Incorporated is a global semiconductor manufacturer that designs, produces and supplies discrete, analog and mixed-signal semiconductor products. Its solutions serve key end markets including automotive, industrial, consumer electronics, personal computing and communications infrastructure, with a worldwide customer base.
AXSM vs DIOD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $391.6M |
| Net Profit | $-28.6M | $10.2M |
| Gross Margin | — | 31.1% |
| Operating Margin | -13.8% | 3.4% |
| Net Margin | -14.6% | 2.6% |
| Revenue YoY | 65.0% | 15.4% |
| Net Profit YoY | 61.9% | 23.8% |
| EPS (diluted) | $-0.55 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $391.6M | ||
| Q3 25 | $171.0M | $392.2M | ||
| Q2 25 | $150.0M | $366.2M | ||
| Q1 25 | $121.5M | $332.1M | ||
| Q4 24 | $118.8M | $339.3M | ||
| Q3 24 | $104.8M | $350.1M | ||
| Q2 24 | $87.2M | $319.8M | ||
| Q1 24 | $75.0M | $302.0M |
| Q4 25 | $-28.6M | $10.2M | ||
| Q3 25 | $-47.2M | $14.3M | ||
| Q2 25 | $-48.0M | $46.1M | ||
| Q1 25 | $-59.4M | $-4.4M | ||
| Q4 24 | $-74.9M | $8.2M | ||
| Q3 24 | $-64.6M | $13.7M | ||
| Q2 24 | $-79.3M | $8.0M | ||
| Q1 24 | $-68.4M | $14.0M |
| Q4 25 | — | 31.1% | ||
| Q3 25 | — | 30.7% | ||
| Q2 25 | — | 31.5% | ||
| Q1 25 | — | 31.5% | ||
| Q4 24 | — | 32.7% | ||
| Q3 24 | — | 33.7% | ||
| Q2 24 | — | 33.6% | ||
| Q1 24 | — | 33.0% |
| Q4 25 | -13.8% | 3.4% | ||
| Q3 25 | -27.0% | 3.0% | ||
| Q2 25 | -24.5% | 2.6% | ||
| Q1 25 | -46.9% | 0.4% | ||
| Q4 24 | -61.1% | 3.5% | ||
| Q3 24 | -59.8% | 6.2% | ||
| Q2 24 | -89.5% | 1.2% | ||
| Q1 24 | -89.7% | 4.3% |
| Q4 25 | -14.6% | 2.6% | ||
| Q3 25 | -27.6% | 3.6% | ||
| Q2 25 | -32.0% | 12.6% | ||
| Q1 25 | -48.9% | -1.3% | ||
| Q4 24 | -63.1% | 2.4% | ||
| Q3 24 | -61.7% | 3.9% | ||
| Q2 24 | -91.0% | 2.5% | ||
| Q1 24 | -91.1% | 4.6% |
| Q4 25 | $-0.55 | $0.23 | ||
| Q3 25 | $-0.94 | $0.31 | ||
| Q2 25 | $-0.97 | $0.99 | ||
| Q1 25 | $-1.22 | $-0.10 | ||
| Q4 24 | $-1.54 | $0.18 | ||
| Q3 24 | $-1.34 | $0.30 | ||
| Q2 24 | $-1.67 | $0.17 | ||
| Q1 24 | $-1.44 | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $377.0M |
| Total DebtLower is stronger | — | $25.7M |
| Stockholders' EquityBook value | $88.3M | $1.9B |
| Total Assets | $689.8M | $2.4B |
| Debt / EquityLower = less leverage | — | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $377.0M | ||
| Q3 25 | $325.3M | $386.4M | ||
| Q2 25 | $303.0M | $327.3M | ||
| Q1 25 | $300.9M | $343.9M | ||
| Q4 24 | $315.4M | $316.1M | ||
| Q3 24 | $327.3M | $319.3M | ||
| Q2 24 | $315.7M | $273.9M | ||
| Q1 24 | $331.4M | $276.0M |
| Q4 25 | — | $25.7M | ||
| Q3 25 | — | $24.9M | ||
| Q2 25 | — | $26.4M | ||
| Q1 25 | — | $20.5M | ||
| Q4 24 | — | $20.7M | ||
| Q3 24 | — | $22.2M | ||
| Q2 24 | — | $20.3M | ||
| Q1 24 | — | $20.9M |
| Q4 25 | $88.3M | $1.9B | ||
| Q3 25 | $73.7M | $1.9B | ||
| Q2 25 | $73.1M | $1.9B | ||
| Q1 25 | $53.2M | $1.8B | ||
| Q4 24 | $57.0M | $1.8B | ||
| Q3 24 | $92.9M | $1.8B | ||
| Q2 24 | $102.9M | $1.8B | ||
| Q1 24 | $144.0M | $1.7B |
| Q4 25 | $689.8M | $2.4B | ||
| Q3 25 | $669.3M | $2.5B | ||
| Q2 25 | $639.8M | $2.5B | ||
| Q1 25 | $596.7M | $2.4B | ||
| Q4 24 | $568.5M | $2.4B | ||
| Q3 24 | $561.5M | $2.4B | ||
| Q2 24 | $548.2M | $2.4B | ||
| Q1 24 | $545.7M | $2.4B |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.01× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | 0.01× | ||
| Q2 24 | — | 0.01× | ||
| Q1 24 | — | 0.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $38.1M |
| Free Cash FlowOCF − Capex | $-18.7M | $12.4M |
| FCF MarginFCF / Revenue | -9.6% | 3.2% |
| Capex IntensityCapex / Revenue | 0.0% | 6.6% |
| Cash ConversionOCF / Net Profit | — | 3.74× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $137.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $38.1M | ||
| Q3 25 | $1.0M | $79.1M | ||
| Q2 25 | $-32.4M | $41.5M | ||
| Q1 25 | $-43.4M | $56.7M | ||
| Q4 24 | $-26.2M | $81.8M | ||
| Q3 24 | $-18.6M | $54.4M | ||
| Q2 24 | $-30.1M | $14.4M | ||
| Q1 24 | $-53.5M | $-31.1M |
| Q4 25 | $-18.7M | $12.4M | ||
| Q3 25 | $988.0K | $62.8M | ||
| Q2 25 | $-32.4M | $21.1M | ||
| Q1 25 | $-43.7M | $40.8M | ||
| Q4 24 | $-26.2M | $62.1M | ||
| Q3 24 | $-18.7M | $39.4M | ||
| Q2 24 | $-30.2M | $-3.5M | ||
| Q1 24 | $-53.6M | $-51.5M |
| Q4 25 | -9.6% | 3.2% | ||
| Q3 25 | 0.6% | 16.0% | ||
| Q2 25 | -21.6% | 5.8% | ||
| Q1 25 | -36.0% | 12.3% | ||
| Q4 24 | -22.1% | 18.3% | ||
| Q3 24 | -17.9% | 11.2% | ||
| Q2 24 | -34.6% | -1.1% | ||
| Q1 24 | -71.4% | -17.1% |
| Q4 25 | 0.0% | 6.6% | ||
| Q3 25 | 0.0% | 4.2% | ||
| Q2 25 | 0.0% | 5.6% | ||
| Q1 25 | 0.3% | 4.8% | ||
| Q4 24 | 0.0% | 5.8% | ||
| Q3 24 | 0.1% | 4.3% | ||
| Q2 24 | 0.1% | 5.6% | ||
| Q1 24 | 0.1% | 6.7% |
| Q4 25 | — | 3.74× | ||
| Q3 25 | — | 5.54× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 9.93× | ||
| Q3 24 | — | 3.95× | ||
| Q2 24 | — | 1.80× | ||
| Q1 24 | — | -2.22× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
DIOD
| Distributor | $253.1M | 65% |
| Direct Sales | $138.5M | 35% |
